AH Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
AH Capital Management's RVMD Position: Q3 2026 in Review
AH Capital Management reduced its Revolution Medicines (RVMD) stake by 15% in Q3 2026, selling an estimated $27.4M and leaving 782,934 shares worth $161M. The position accounts for 0.81% of the portfolio, ranked #4.
AH Capital Management first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $173M in Q2 2026. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- AH Capital Management held 782,934 shares of Revolution Medicines worth $161M as of Q3 2026.
- AH Capital Management sold 138,165 Revolution Medicines shares in Q3 2026, an estimated $27.4M.
- Revolution Medicines made up 0.81% of AH Capital Management's portfolio in Q3 2026, its #4 holding.
- AH Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
- AH Capital Management's Revolution Medicines position peaked at $173M in Q2 2026.
- 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on AH Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.